Thanks for posting.
I think it's fairly obvious at this point that Dixon does not have much of a company in Exopharm. We definitely didn't 'leap' last year and Baldwin eventually realized we were never going to leap at all and left the company. There is no near-term revenue coming.
After talking to Dixon on the phone I realized he is very similar to David McLoughlin - the CEO of Buddy (BUD). At the time, as soon as I realized he was a dishonest guy I got out of the company and watched him run the company into the ground (40 cents to 0.8 cents) over the next several years.
I have a feeling the same will happen with Exopharm, which is why I haven't taken it off my watchlist as I'm curious to see what happens next. I recommend holders to have a chat with Dixon on the phone.
- Forums
- ASX - By Stock
- Anyone spoken to the company?
Thanks for posting.I think it's fairly obvious at this point...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.60M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $2.183K | 120.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 117646 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 695000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 117646 | 0.017 |
1 | 311565 | 0.016 |
1 | 500000 | 0.015 |
1 | 70000 | 0.014 |
1 | 777777 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 695000 | 1 |
0.020 | 325000 | 2 |
0.021 | 15321 | 2 |
0.022 | 780953 | 2 |
0.025 | 596153 | 5 |
Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |